Cargando…
How does re-classification of variants of unknown significance (VUS) impact the management of patients at risk for hereditary breast cancer?
BACKGROUND: The popularity of multigene testing increases the probability of identifying variants of uncertain significance (VUS). While accurate variant interpretation enables clinicians to be better informed of the genetic risk of their patients, currently, there is a lack of consensus management...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158111/ https://www.ncbi.nlm.nih.gov/pubmed/35641994 http://dx.doi.org/10.1186/s12920-022-01270-4 |